Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

BACKGROUND: Kidneys from deceased donors are being used to meet the growing need for grafts. However, delayed graft function (DGF) and acute rejection incidences are high, leading to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Transl Med
Päätekijät: Sun, Qipeng, Huang, Zhengyu, Han, Fei, Zhao, Ming, Cao, Ronghua, Zhao, Daqiang, Hong, Liangqing, Na, Ning, Li, Heng, Miao, Bin, Hu, Jianmin, Meng, Fanhang, Peng, Yanwen, Sun, Qiquan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842532/
https://ncbi.nlm.nih.gov/pubmed/29514693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1422-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia